Home/Filings/4/0001209191-22-005890
4//SEC Filing

Sacks Natalie 4

Accession 0001209191-22-005890

CIK 0001708493other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:07 PM ET

Size

5.6 KB

Accession

0001209191-22-005890

Insider Transaction Report

Form 4
Period: 2022-01-28
Sacks Natalie
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-01-28+155,000155,000 total
    Exercise: $5.03Exp: 2032-01-27Common Stock (155,000 underlying)
Footnotes (1)
  • [F1]1/48th of the total stock option will vest and become exercisable monthly on the same day of each month following the vesting commencement date of January 28, 2022, subject to the continuing employment of the Reporting Person on each vesting date.

Issuer

Harpoon Therapeutics, Inc.

CIK 0001708493

Entity typeother

Related Parties

1
  • filerCIK 0001683811

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:07 PM ET
Size
5.6 KB